IP Library Granted Patent US 8,975,019
Granted Patent B2
US 8,975,019 · App. 12/906,678 · Granted Mar 10, 2015

Deducing exon connectivity by RNA-templated DNA ligation/sequencing

Inventors: Phillip D. Zamore (Northborough, MA); Melissa J. Moore (Chestnut Hill, MA); Christian Roy (Shrewsbury, MA)
Assignee: University Of Massachusetts
C12N15/1031C12N15/1096C12Q1/6806C12Q1/6869C12N15/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,975,019
App. No.
12/906,678
Granted
Mar 10, 2015
Kind
B2
Abstract

A technology is described that is capable of generating high-throughput sequencing (HTS) read length DNA products to accurately and reliably provide exon connectivity information for alternatively spliced isoforms. The method is not limited by the initial size of the isoform as the technology removes the template oligonucleotide sequence and a newly formed full length ligated product provides an HTS-compatible read length sequence that comprises information that corresponds to the consecutive order of the exons in the original template oligonucleotide.

Claims (24)

1. A method, comprising:

a) providing:

i) a plurality of ligamer subsets, wherein each of said ligamer subsets comprise a plurality of different complementary regions, wherein at least two of said plurality of different complementarity regions are separated by a central region, wherein said central region has a different exon-specific barcode sequence, wherein each said different barcode sequence comprises a different identifier code for a different specific exon, wherein said at least two of said different complementarity regions are complementary to the flanking regions of said different specific exon; and

ii) a template oligonucleotide, wherein said oligonucleotide comprises a plurality of hybridization sites;

b) mixing said plurality of ligamers with said template oligonucleotide under conditions such that said complementarity regions bind to said hybridization sites;

c) ligating said ligamers to create a full length ligated product (FLLP);

d) amplifying said FLLP under conditions to create a DNA product; and

e) identifying the consecutive order of said barcodes within said DNA product.

2. The method of claim 1 , wherein said template oligonucleotide comprises an mRNA oligonucleotide.

3. The method of claim 2 , wherein said mRNA oligonucleotide comprises a plurality of said different exons.

4. The method of claim 1 , wherein each of said barcodes corresponds to one of said different exons.

5. The method of claim 1 , wherein said identifying comprises nucleotide sequencing.

6. The method of claim 5 , wherein said sequencing comprises high throughput sequencing.

7. The method of claim 1 , wherein said template oligonucleotide ranges between approximately 100-100,000 nt.

8. The method of claim 1 , wherein said ligamer ranges between approximately 5-2,000 nt.

9. The method of claim 1 , wherein said DNA product ranges between approximately 100-1000 nt.

10. A kit, comprising:

a) a first container comprising a plurality of ligamer subsets, wherein each of said ligamer subsets comprise a plurality of different complementarity regions, wherein at least two of said plurality of different complementarity regions are separated by a central region, wherein said central region has a different exon-specific barcode sequence, wherein each different exon-specific barcode sequence comprises a different identifier code for a different specific exon, wherein said at least two of said different complementarity regions are complementary to the flanking regions of said different specific exon; and

b) a second container comprising a template oligonucleotide, wherein said oligonucleotide comprises a plurality of hybridization sites;

c) a third container comprising buffers and reagents for hybridizing said ligamers and template oligonucleotide;

d) a fourth container comprises a ligase and associated buffers and reagents; and,

e) a set of instructions for;

i) hybridizing said ligamers and said template oligonucleotide;

ii) ligating said ligamers to create a full length ligated product.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2010
From: ZAMORE, PHILLIP D.; MOORE, MELISSA J.; ROY, CHRISTIAN
To: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Reel/Frame 025762/0382 →
Continuity (2)
Provisional Application 61252868 · Oct 19, 2009
Related Publication 20110092375A1 · Apr 21, 2011